EUROMED AG
Ad hoc-Service: EUROMED AG english
Ad hoc announcement processed and transmitted by DGAP.
The issuer has the sole responsibility of this announcement.
——————————————————————————–
Euromed AG published results for 2000
Fürth, 29 March 2001. Euromed AG (Neuer Markt: sec. ID 570 680), manager of a
modern, high performance medical clinic, reached a consolidated sales volume of
31.0 million DM for the year 2000. The construction of the clinic extension
that lasted from April to December 2000 put a burden on clinic operations and
therefore affected sales, so that sales revenues were 5.4% lower than during
the previous fiscal year (32.8 million DM). The group booked a loss of 2.3
million DM, compared to 2.1 million DM in the year 1999. EBITDA amounted to 0.5
million DM, compared to 3.8 million DM in the previous year.
However, the first two months in the current fiscal year have already exceeded
expectations. The sales volume increased during this period to 5.6 million DM
(plus 1.4 million DM, or plus 32.6% compared to the same period last year). The
sales figures for the current month are exceeding expectations. Therefore, very
positive developments are anticipated for the first quarter of 2001. Euromed AG
is also expecting positive results for the first half year of 2001. The sales
growth in 2001 is expected to be approx. 20%, compared the fiscal year 2000.
Contact:
Michael Wünsche, CEO of Euromed AG,
Tel: +49 (0)911-97 14 600, Fax: +49 (0)911-97 14 607,
E-mail: wuensche@euromed.de
end of ad hoc announcement, (c) DGAP 29.03.2001
——————————————————————————–
WKN: 570680; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
290824 Mär 01
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found